Associated Papers
Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations in HIV-2 Integrase: A Phenotypic Analysis Using an Expanded Panel of Site-Directed Mutants.
Smith RA et al.
The Journal of Infectious Diseases, 2022
Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness.
Abram ME et al.
Antimicrobial Agents and Chemotherapy, 2013
Select a paper to view details